Mastering FDA Core Medical Device Files: DHF, DMR, DHR

Date
Apr 29, 2026
Time
01 : 00 PM EST
13DAYS
TO GO
Speaker
John E. Lincoln
Industry
Pharmaceuticals
Duration
120 Minutes
Group Bookings (6+)
+(877) 629-3710 or cs@msausaconnect.com
Payment Support (ACH/Check)
+(877) 629-3710 or cs@msausaconnect.com
Registration Options
SPECIAL OFFER Unlock $30 Discount SAVE30
Description

Device Master Record (DMR) & Device History Record (DHR) Training: Ensuring Compliance & Effective Technical Documentation Course Description

Medical device manufacturing is not an easy process. If anything goes wrong, the entire batch of products is at stake. Is there any solution to it? DHF, DMR, and DHR are the three Ds of medical device that needs to be managed carefully.

Even though these files serve different purposes, it is essential to understand how they are mutually inclusive for effective technical documentation. This seminar offers a deeper insight into the documentation part of medical device manufacturing. Moreover, the seminar will cover the latest requirements proposed by FDA and European Union.

Let’s dive deeper into the topics covered!

Breaking down each of these terms for a better understanding of freshers into medical device manufacturing.

  • Design History File (DHF): Includes an entire history of the device’s design, which justifies the currently approved design.
  • Device Master Record (DMR): Associated with device production and highlights the requirements like material, equipment, and surroundings.
  • Device History Record (DHR): Contains production-related documents which consist of dates, quantity, and labels of final products.

It is essential to have proper knowledge of technical documentation because these are submitted to the FDA. Additionally, these play an important role in pre-market approval of the device. It is crucial for regulatory compliance and this course focuses on future trends and the typical table of contents.

The core purpose of this seminar is to highlight the general safety and performance requirements. Moreover, the coach pays special attention to the file auditing process by FDA and notified the body to make the execution of the concept easier for professionals.

Learning Objectives

Below are the topics discussed:

Session 1

  • Introduction
  • Design Control Under 21 CFR 820.30
  • Design and Development Planning under ISO 13485:2016 7.3
  • The U.S. FDA's DHF
  • The EU MDR's D&DPF
  • MDR's "General Safety and Performance Requirements"
  • Device Classification - U.S. FDA vs. EU MDD
  • Design Files' "Typical" Contents
  • The DMR and DHR / Lot / Batch Record TD Expected Contents

Session 2

  • Risk Management / File Under ISO 14971
  • Narrative
  • Hazzard Analysis
  • FTA
  • D-, P-, and U-FMECA's
  • Report

Session 3

  • Human Factors / Use Engineering Under IEC 62366-1:2015
  • The User Interface
  • The 9 Stages
  • The HF / UE File

Session 4

  • Putting It All Together
  • Design Control
  • The Team
  • Concurrent Compilation of the Three Files
  • Derivative Documents Development
  • Completion
  • FDA and NB Audit Focus
  • Final Q & A
Who Should Attend
  • Quality and Research Analysts: Learn to verify regulatory compliance efficiently and maintain accurate documentation in accordance with FDA and ISO standards.
  • R&D Professionals: Understand how to incorporate Design History Files (DHF) and Device Master Records (DMR) when making innovative changes to devices.
  • Engineering Teams: Gain insights into device design and mechanisms to ensure proper documentation and regulatory alignment.
  • Production / Manufacturing Professionals: Learn to estimate project timelines and align the manufacturing process with Device History Records (DHR) requirements.
  • Marketing Professionals: Acquire a clear understanding of the product’s development and compliance processes, enabling effective marketing strategies grounded in accurate device knowledge.
John E. Lincoln

John E. Lincoln

Principal of J. E. Lincoln and Associates

John E. Lincoln is the Principal of J. E. Lincoln and Associates, a consulting company with over 41 years of experience in U.S. FDA-regulated industries, 27 of which as head of his own consulting company. John has worked with companies from start-ups to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China, and Taiwan. He specializes in quality assurance, regulatory affairs, QMS problem remediation, FDA responses, new/changed product 510(k)s, process/product/equipment incl+D33uding QMS and software validations, ISO 14971 product risk management files/reports, Design Control / Design History Files, Technical Files. He's held Manufacturing Engineering, QA, QAE, and Regulatory Affairs positions at the Director and VP (R&D) levels.  In addition, John has prior experience in the military, government, electronics, and aerospace. He has published numerous articles in peer-reviewed journals, including 5 chapters in the RAPs validation textbook, and conducted workshops and webinars worldwide on regulatory issues. John is a graduate of UCLA.